Minimally invasive and conventional glucose monitoring did not differ for long-term glycemic control in insulin-treated diabetes

Muthusamy, Kalpana; Smith, Steven A.; Dinneen, Sean F.; Dennedy, M. Conall; Newman, S. P.; Cooke, D.
October 2009
ACP Journal Club;10/20/2009, Vol. 151 Issue 4, p4
Academic Journal
The article discusses a study on the relation between minimally invasive glucose monitoring and conventional monitoring in patients with poorly controlled insulin-treated diabetes. The results of the study indicate a relative 12.5% change in hemoglobin (HbA) level. However minimally invasive glucose monitoring did not improve long-term glycemic control more than conventional monitoring.


Related Articles

  • One-Year Glycemic Control With a Sulfonylurea Plus Pioglitazone Versus a Sulfnylurea Plus Metformin in Patients With Type 2 Diabetes. Hanefeld, Markolf; Brunetti, Paolo; Schernthaner, Guntram H.; Matthews, David R.; Charbonnel, Bernard H. // Diabetes Care;Jan2004, Vol. 27 Issue 1, p141 

    OBJECTIVE — The goal was to assess the 1-year efficacy and safety of the addition of pioglitazone or metformin to existing sulfonylurea (SU) therapy in patients with inadequately controlled type 2 diabetes. RESEARCH DESIGN AND METHODS — In this multicenter, double-blind study,...

  • Estimating Plasma Glucose from Interstitial Glucose: The Issue of Calibration Algorithms in Commercial Continuous Glucose Monitoring Devices. Rossetti, Paolo; Bondia, Jorge; Vehí, Josep; Fanelli, Carmine G. // Sensors (14248220);2010, Vol. 10 Issue 12, p10936 

    Evaluation of metabolic control of diabetic people has been classically performed measuring glucose concentrations in blood samples. Due to the potential improvement it offers in diabetes care, continuous glucose monitoring (CGM) in the subcutaneous tissue is gaining popularity among both...

  • Closed-loop for type 1 diabetes - an introduction and appraisal for the generalist. Bally, Lia; Thabit, Hood; Hovorka, Roman // BMC Medicine;1/23/2017, Vol. 15, p1 

    Background: Rapid progress over the past decade has been made with the development of the 'Artificial Pancreas', also known as the closed-loop system, which emulates the feedback glucose-responsive functionality of the pancreatic beta cell. The recent FDA approval of the first...

  • Premixed insulin analogues reduced fasting glucose, HbA1c levels.  // Endocrine Today;11/10/2008, Vol. 6 Issue 20, p20 

    The article discusses a study of glycemic control offered by premixed insulin analogues to patients with type 2 diabetes, which was published in the 2008 issue of "Annals of Internal Medicine." Researchers said pre-mixed insulin analogues may be as effective as pre-mixed human insulin in...

  • Glycemic Variability and Type 2 Diabetes Mellitus. GRIBOVSCHI, Mihaela; ŢIGAN, Ştefan; HÂNCU, Nicolae // Applied Medical Informatics;Jan2013, Vol. 32 Issue 1, p53 

    Aim: The purpose of the present study was to quantify glucose variability in type 2 diabetic patients and establishing relationship with cardiometabolic parameters and type of glucose-lowering treatment. Material and Methods: Continuous glucose monitoring (CGM) was used in 373 type 2 diabetic...

  • A Fully Human, Allosteric Monoclonal Antibody That Activates the Insulin Receptor and Improves Glycemic Control. Bhaskar, Vinay; Goldfine, Ira D.; Bedinger, Daniel H.; Lau, Angela; Kuan, Hua F.; Gross, Lisa M.; Handa, Masahisa; Maddux, Betty A.; Watson, Susan R.; Zhu, Shirley; Narasimha, Ajay J.; Levy, Raphael; Webster, Lynn; Wijesuriya, Sujeewa D.; Naichi Liu; Xiaorong Wu; Chemla-Vogel, David; Tran, Catarina; Lee, Steve R.; Wong, Steve // Diabetes;May2012, Vol. 61 Issue 5, p1263 

    Many patients with diabetes mellitus (both type 1 and type 2) require therapy to maintain normal fasting glucose levels. To develop a novel treatment for these individuals, we used phage display technology to target the insulin receptor (INSR) complexed with insulin and identified a high...

  • Influence of and Optimal Insulin Therapy for a Low-Glycemic Index Meal in Children With Type 1 Diabetes Receiving Intensive Insulin Therapy. Ryan, Rochelle L.; King, Bruce R.; Anderson, Donald G.; Attia, John R.; Collins, Clare E.; Smart, Carmel E. // Diabetes Care;Aug2008, Vol. 31 Issue 8, p1485 

    OBJECTIVE--The purpose of this study was to quantify the effects of glycemic index on postprandial glucose excursion (PPGE) in children with type 1 diabetes receiving multiple daily injections and to determine optimal insulin therapy for a low-glycemic index meal. RESEARCH DESIGN AND...

  • Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 Diabetes. Raccah, Denis; Sulmont, Véronique; Reznik, Yves; Guerci, Bruno; Renard, Eric; Hanaire, Hélène; Jeandidier, Nathalie; Nicolino, Marc // Diabetes Care;Dec2009, Vol. 32 Issue 12, p2245 

    OBJECTIVE -- To compare the improvements in glycemic control associated with transitioning to insulin pump therapy in patients using continuous glucose monitoring versus standard blood glucose self-monitoring. RESEARCH DESIGN AND METHODS -- The RealTrend study was a 6-month, randomized,...

  • Achieving HbA1c targets and reducing risk of complications. Devendra, Devasenan // GP: General Practitioner;11/14/2008, p34 

    The article reviews the evidence for good glycemic control in type-2 diabetes. It discusses studies that have demonstrated the potential benefits of improving glycemic control to achieve HbA1c targets in patients with type-2 diabetes. It notes that the United Kingdom Prospective Diabetes Study...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics